Eurycomanone and the SHBG hypothesis
Tongkat ali (Eurycoma longifolia) is a Southeast Asian root standardized in many products to its quassinoid eurycomanone and to a group of small peptides. The most discussed mechanism is a reduction in sex hormone binding globulin (SHBG), the carrier protein that holds testosterone in an inactive form. By lowering SHBG, the proposal is that a larger share of existing testosterone becomes free and bioavailable rather than the body manufacturing more.
Who the trials actually studied
Notably, the more favorable human results tend to come from men who were stressed, older, or had lower baseline testosterone, rather than young men with normal levels. Some trials in these groups report modest rises in free or total testosterone and reductions in stress markers, framed as supporting endogenous production rather than supplying a hormone.
Trials are generally small, short, and use varying extracts, so results are preliminary and not uniform. This is general educational information, not medical advice. Because effects on hormones are claimed, anyone with a hormone-sensitive condition, prostate disease, or who takes medication should consult a qualified professional before use, and suspected low testosterone should be evaluated clinically.